Genetics
Found 1 companies.
🏢 Abbott
👥 1001-5000💰 $100.0k Post-IPO Debt on 2011-03-15🫂 on 2021-07-08PharmaceuticalBiotechnologyEmergency MedicineNutritionMedicalMedical DeviceManufacturingHealth CareGeneticsHealth Diagnostics
Website LinkedIn Email Phone # Facebook Twitter

Abbott is engaged in pharmaceuticals and manufacturing healthcare products. It developed the first HIV blood-screening test. Its product portfolio includes Norvir, a treatment for HIV; Synthroid, a synthetic thyroid hormone; Depakote, an anticonvulsant drug; and Humira, a drug for rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and more.